Fund Holdings — BVF INC/IL

Total Portfolio Value
$3.14B
Total Bought
$356.39M
Total Sold
$337.15M
Net Transaction
+$19.23M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
NEKTAR THERAPEUTICS(NKTR)1,559,5952,559,595+1,000,00065,940184,1635.87%+118,223
ALKERMES PLC(ALKS)02,000,000+2,000,000070,7202.25%+70,720
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)19,751,28416,001,284-3,750,000260,322298,2649.50%+37,942
SUTRO BIOPHARMA INC(STRO)01,251,788+1,251,788031,1820.99%+31,182
KYMERA THERAPEUTICS INC(KYMR)5,502,7105,502,7100428,166458,32114.60%+30,155
DISC MEDICINE INC(IRON)650,0001,272,312+622,31251,61781,3522.59%+29,735
MIRUM PHARMACEUTICALS INC(MIRM)1,495,2901,584,727+89,437118,113146,3974.66%+28,284
PALVELLA THERAPEUTICS INC NE(PVLA)879,009960,989+81,98092,006119,7873.82%+27,781
CULLINAN THERAPEUTICS INC(CGEM)5,750,6835,750,683059,52081,7172.60%+22,198
TYRA BIOSCIENCES INC(TYRA)2,127,6651,976,196-151,46955,93675,6882.41%+19,752
CRESCENT BIOPHARMA INC.(CBIO)2,748,7632,748,763032,60050,4951.61%+17,894
ANTERIS TECHNOLOGIES GLOBAL(AVR)03,000,000+3,000,000016,6500.53%+16,650
MONTE ROSA THERAPEUTICS INC(GLUE)3,835,8864,460,886+625,00060,14773,3822.34%+13,235
XOMA ROYALTY CORPORATION2,590,3032,590,303068,87681,2582.59%+12,382
STOKE THERAPEUTICS INC(STOK)2,265,6742,547,557+281,88371,91282,9482.64%+11,036
REVOLUTION MEDICINES INC(RVMD)3,356,7822,856,782-500,000267,368277,8228.85%+10,454
ELEDON PHARMACEUTICALS INC(ELDN)6,293,2826,293,28209,50319,3830.62%+9,880
GH RESEARCH PLC(GHRS)8,827,7128,650,158-177,554112,112121,6213.87%+9,509
ONKURE THERAPEUTICS INC(OKUR)01,978,972+1,978,97208,1930.26%+8,193
IMMUNIC INC(IMUX)7,652,9727,652,97204,0848,4950.27%+4,410
ANNEXON INC(ANNX)9,128,0808,698,173-429,90745,82348,1881.54%+2,365
TENAX THERAPEUTICS INC(TENX)339,549339,54904,1395,4290.17%+1,290
INVENTIVA SA(IVA)686,040686,04003,1903,8080.12%+617
TSCAN THERAPEUTICS INC(TCRX)5,226,0745,564,290+338,2165,2265,6200.18%+394
X4 PHARMACEUTICALS INC(XFOR)2,233,7422,233,74208,9359,2250.29%+290
ENGENE HOLDINGS INC
*W EXP 10/31/202
945,402945,40202,4012,4860.08%+85
IMAGENEBIO INC(IMA)802,1021,110,002+307,9005,5355,5500.18%+16
AVALO THERAPEUTICS INC(AVTX)1,355,2571,632,845+277,58824,61124,3780.78%-233
MOLECULAR PARTNERS AG(MOLN)1,353,9681,353,96805,8225,3620.17%-460
COMPASS THERAPEUTICS INC(CMPX)7,764,8427,764,842041,69741,0761.31%-621
FOGHORN THERAPEUTICS INC(FHTX)5,302,0005,842,000+540,00028,63127,9250.89%-706
AC IMMUNE SA(ACIU)19,822,43619,822,436062,24254,5121.74%-7,731
4D MOLECULAR THERAPEUTICS IN4,629,2892,879,289-1,750,00034,72026,8060.85%-7,913
AXSOME THERAPEUTICS INC(AXSM)45,7570-45,7578,3570—-8,357
ZYMEWORKS INC(ZYME)3,938,6413,734,142-204,499103,70493,5032.98%-10,202
IMMUNOCORE HLDGS PLC(IMCR)1,488,9751,294,463-194,51250,29439,0281.24%-11,266
PEPGEN INC(PEPG)1,915,0000-1,915,00012,4670—-12,467
SEPTERNA INC(SEPN)1,720,7821,353,249-367,53347,97532,5191.04%-15,457
KURA ONCOLOGY INC(KURA)8,617,1628,445,769-171,39389,53268,6642.19%-20,868
INVIVYD INC(IVVD)19,525,00019,525,000048,22725,3830.81%-22,844
XENCOR INC(XNCR)7,133,7207,133,7200109,21786,0332.74%-23,185
REPARE THERAPEUTICS INC10,333,6000-10,333,60026,8670—-26,867
OLEMA PHARMACEUTICALS INC(OLMA)5,295,8935,295,8930132,39778,9622.52%-53,436
ABIVAX SA(ABVX)508,0310-508,03168,5110—-68,511
STRUCTURE THERAPEUTICS INC3,479,0223,459,358-19,664241,966166,7415.31%-75,225
Page 1 of 1
BVF INC/IL — 13F Holdings — Q1 2026 | TickerTrail